Peer-influenced content. Sources you trust. No registration required. This is HCN.
Oncology News Central (ONC)
The FDA has withdrawn approval for infigratinib in advanced cholangiocarcinoma following Helsinn Healthcare SA’s request, citing recruitment difficulties for a confirmatory trial.
Oncology, Medical June 17th 2024
MDLinx
Sexsomnia, a sleep disorder involving unconscious sexual behaviors, presents significant diagnostic and treatment challenges. Comprehensive evaluations and behavioral interventions are key to managing this condition.
All Specialties May 22nd 2024
Cleveland Clinic Journal of Medicine (CCJM)
In a complex case of pseudomyxoma peritonei, detailed imaging and cytological analysis were crucial in identifying a rare pancreaticobiliary origin, highlighting the importance of a thorough diagnostic approach in unusual presentations of ascites.
Gastroenterology May 13th 2024
Rare Disease Advisor
In cases of transthyretin-mediated amyloid cardiomyopathy, standard diagnostic techniques may not always detect cardiac abnormalities, as evidenced by a patient with the rare Tyr78Phe mutation who lacked typical imaging markers but confirmed amyloid deposits through biopsy.
Cardiology May 1st 2024
FAP News Today
In the realm of rare diseases, early diagnosis is a critical challenge. Machine learning is emerging as a pivotal tool in identifying familial amyloid polyneuropathy (FAP) patients, promising a new era of precision in genetic testing and timely treatment initiation.
Cardiology March 25th 2024
This article illustrates a case of bullosis diabeticorum, spotlighting the condition’s clinical presentation, diagnosis, and management, offering key insights for physicians in the early detection and care of this rare diabetic complication.
Dermatology March 13th 2024